Posters
« Back
The use of the IV microtracer technique to drive formulation optimisation
EP20591
Poster Title: The use of the IV microtracer technique to drive formulation optimisation
Submitted on 20 Dec 2013
Author(s): Vanessa Zann, Paul Dickinson, Wang Wang Lee, George Kirk, Owen Jones, Andy Gray, Davindera Singh Sanghera, Mark Seymour, Jo Collier, Lloyd Stevens, Julie Dent
Affiliations: AstraZeneca, Xceleron Ltd, Quotient Clinical Limited, Arrow Therapeutics
Poster Views: 1,273
View poster »


Poster Information
Abstract: Strategy: Use IV microtracer technique to de risk compounds with PK issues and drive formulation development.
Summary: Strategy: Use IV microtracer techniquer to de risk compounds with PK issues and drive formulation development.
Report abuse »
Creative Commons

Related Posters


Clinical and Scientific Evidence for the Safety and Efficacy of XanMax® Lutein/Zeaxanthin
Priya, M.K., Lelah, M.

Lutein Esters are more Bioavailable than Free Lutein
Michael Lelah

Primary Human Hepatocytes 3D in vitro Culture Model for Studying Hepatic Function
Sujoy Lahiri, Julia Tritapoe, Kate Comstock, Michael F. Millett, Mark Kennedy, Theresa V. Nguyen, Deborah K. Tieberg, David T. Kuninger

VITVO: Mimicking In Vivo Complexity By The Innovative 3D Model
Olivia Candini1, Giulia Grisendi1, Elisabetta Manuela Foppiani1, Matteo Brogli1, Beatrice Aramini2, Valentina Masciale3, Carlotta Spano1, Tiziana Petrachi4, Elena Veronesi4, Pierfranco Conte5,6, Giorgio Mari1 & Massimo Dominici1,3

Characterization of patient-derived organoids cultured on a gas-rich, liquid-liquid interface
James T. Shoemaker, Katherine R. Richardson, Jamie Arnst, Adam Marcus, Jelena Vukasinovic